Sharp Biomedical Closes Pre-Seed Funding Led by Gener8tor to Advance Outpatient Spine Procedures for Early-to-Mid-Stage Chronic PainOctober 13, 2026
Armenia Grants First Marketing Authorizations to Botensilimab Plus Balstilimab in Previously Treated MSS mCRCOctober 13, 2026
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026By AdminBitOctober 13, 20260 This is a paid press release. Contact the press release distributor directly with any enquiries.
